Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
about
Silaffins in Silica Biomineralization and Biomimetic Silica PrecipitationFunctionalized nanoporous silica for the removal of heavy metals from biological systems: adsorption and applicationBiocompatibility assessment of Si-based nano- and micro-particlesAssessing the axonal translocation of CeO2 and SiO2 nanoparticles in the sciatic nerve fibers of the frog: an ex vivo electrophysiological studyNovel/conceptual floating pulsatile system using high internal phase emulsion based porous material intended for chronotherapyMolecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.Porous silicon nanoparticles for cancer photothermotherapyComparison of oxidized porous silicon with bare porous silicon as a photothermal agent for cancer cell destruction based on in vitro cell test results.The photophysics of porous silicon: technological and biomedical implications.Study of the release mechanism of Terminalia chebula extract from nanoporous silica gel.Development of duloxetine hydrochloride loaded mesoporous silica nanoparticles: characterizations and in vitro evaluationCisplatin-loaded porous Si microparticles capped by electroless deposition of platinumEnhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxideUse of degradable and nondegradable nanomaterials for controlled release.Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.pH-triggered release of vancomycin from protein-capped porous silicon filmsPorous silicon in drug delivery devices and materials.Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.Characterization and Bioavailability Study of Baicalin-mesoporous Carbon Nanopowder Solid Dispersion.Anti-Metastatic and Anti-Angiogenic Activities of Core-Shell SiO2@LDH Loaded with Etoposide in Non-Small Cell Lung Cancer.Aerosol route to functional nanostructured inorganic and hybrid porous materials.Silicon-polymer hybrid materials for drug delivery.Oral formulation strategies to improve solubility of poorly water-soluble drugs.Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?Nanostructured porous silicon-mediated drug delivery.Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.Mesoporous silica formulation strategies for drug dissolution enhancement: a review.Porous calcium carbonate as a carrier material to increase the dissolution rate of poorly soluble flavouring compounds.Porous silicon confers bioactivity to polycaprolactone composites in vitro.Uniform and size-tunable mesoporous silica with fibrous morphology for drug delivery.Porous carriers for controlled/modulated drug delivery.β-TCP porous pellets as an orthopaedic drug delivery system: ibuprofen/carrier physicochemical interactions.Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery.High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.Cationic surfactants-modified natural zeolites: improvement of the excipients functionality.Ionogels as drug delivery system: one-step sol-gel synthesis using imidazolium ibuprofenate ionic liquid.Drug silica nanocomposite: preparation, characterization and skin permeation studies.Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug.Probing the mobility of ibuprofen confined in MCM-41 materials using MAS-PFG NMR and hyperpolarised-(129)Xe NMR spectroscopy.Silica-based mesoporous materials as drug delivery system for methotrexate release.
P2860
Q26795747-25957268-9367-4476-97F3-5B3F9B1A1238Q28387911-8D2E028F-27B7-4CE3-AFF0-4BD74B75C12DQ28389467-C4ED16CC-2F93-47BD-8C42-65B2F932A237Q28395105-364C02A0-F91C-4CEC-8D5C-2D0A11084813Q33563566-2CF0767B-F47B-46B9-9E0C-61040ED41DBAQ33770353-B6B10810-2FD8-4039-B07D-BA6DBBA0E54CQ33945015-CD897E25-6B73-441B-B085-F803D5BDCA16Q34096953-E221E4D7-EBEF-4CBF-8797-DC204A63321CQ34411648-AD1FE814-9735-4119-AEDD-86E66BD60CE8Q34450025-A6CAE3DC-2BFF-4535-9FF3-23DA841ECF2CQ35868336-C884E373-9095-4D8C-9923-D76FFCACCD1DQ36039437-42D3611B-9EA7-4778-9A73-8042F59F4E55Q36358743-457DF82E-13BC-4F3C-82B9-7EDFD6289C41Q36917951-A81597DE-C000-4A40-BD3A-5B6B8EE888B0Q36918057-056EB54C-C5CF-4D1B-B26E-730CA9C4AAC5Q37167339-E629F49C-E2C0-40E0-A0AD-B8AF118B1163Q37174934-5007C35A-B5C7-4B4F-B830-77C7D706FF77Q37183352-A465B950-EBF9-49B9-B4F8-76A3FF899FCBQ37394713-83D6743B-4E9E-425E-BE16-29B13CB74DB7Q37404656-FBD4E7EE-C7A3-4344-8D3D-47229E0CABECQ37801884-246E8B8C-C831-4734-B09B-6F5880435E42Q37855825-1E017943-E2BC-468D-A862-566182C819CCQ37910262-A27C42DD-D8A0-4C11-ACE6-342616D218F9Q38024311-282D035D-1FC0-4F75-A883-43FB051BB505Q38221242-A1DC04BE-43A6-4396-9B7E-7AE2CF8A9CE2Q38257177-5E168169-0D6D-45C2-ADBF-9CB984B45229Q38628433-E4C1F5C0-DE7E-4DF5-AEE1-1605CAD1CCE2Q38907190-700E29AA-8A2F-498C-828F-23FCB62CD452Q39036642-9AEBF1F7-B7BA-48A4-9E07-C25F50FDE784Q39388680-4AF73E61-EC16-4CCB-854C-D22DD126895FQ39823170-11A465D4-8EA5-411B-9EFF-C69E82F4C885Q41532524-CAC75314-EEF6-4E7E-8E40-9A73B4D3D306Q42027067-CDF0704A-4DFF-4146-BD0B-A039328B3DE4Q42661929-C108D150-9E05-45A8-96AA-9DC1774D3C08Q43109675-7927621D-22B4-454C-94D6-4C362CB5E5CFQ43213690-14BDE040-EF26-442C-8EBA-0D7F681007AAQ45229293-BE4FD69D-0A25-4F1A-A9BD-08AC888984A7Q46243234-ECC672B2-0ECD-4F31-926F-7F7B3B4A68ADQ46882576-3760A276-5896-4CA3-A3CB-2E3CEFD776C5Q46890448-BD646095-369F-46BF-A49F-1CE76E54F509
P2860
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
@en
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
@nl
type
label
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
@en
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
@nl
prefLabel
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
@en
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
@nl
P2093
P50
P1476
Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property
@en
P2093
Tourné-Péteilh C
P304
P356
10.1016/J.EJPB.2003.12.007
P407
P577
2004-05-01T00:00:00Z